Immuno-Oncology

Browse venture capital firms focused on Immuno-Oncology.

Explore VC firms that invest in Immuno-Oncology. Filter by country and stage to refine results.

2 of 1000 firms
Filters:
Boehringer Ingelheim Venture Fund favicon
Boehringer Ingelheim Venture Fund
Germany, United States, China

The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation. It invests in pioneering science with the potential for significant patient benefit, focusing on areas like immunology, regenerative medicine, and digital health. The fund provides financial support and strategic guidance to portfolio companies.

Founded 2010
Investment Stages
Seed
Series A
Series B
Markets
Immunomodulation
Immuno-Oncology
Tissue Regeneration
New Therapeutic Modalities
Gene Therapy
Cell-based therapeutics
Microbiome
Antiinfectives
Patients Care Management
Digital Health
Jeito Capital favicon
Jeito Capital
France

Jeito Capital is a leading global investment company focused on biopharmaceuticals. They finance and accelerate cutting-edge medical innovation with a patient benefit approach, supporting entrepreneurs through significant capital contributions and expert guidance.

Founded 2018
Investment Stages
Series A
Series B
Markets
Biopharmaceuticals
Oncology
Ophthalmology
Rare Skeletal Diseases
Severe Respiratory Diseases
Fibrosis
Immuno-oncology
Cardiovascular Disease
Immuno-Oncology Therapies
Auto-Immune Diseases
Neuromuscular Diseases
Cell Therapy
Gene Therapy